Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action
- DOI
- 10.1002/alz.71521
- Published
- 2026-06
- Container
- Alzheimer's & Dementia
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71521,
title = {Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action},
author = {Nick Corriveau‐Lecavalier and Neus Falgàs and Deepti Putcha and Jonathan Graff‐Radford and Keir X. X. Yong and Baayla D. C. Boon and Rosaleena Mohanty and Eric Westman and Colin Groot and David T. Jones and Lea T. Grinberg and Gil D. Rabinovici and Jennifer L. Whitwell and Liana G. Apostolova and Melissa E. Murray and Dustin B. Hammers and Suzanne E. Schindler and Inga Atonsdottir and Elizabeth K. Rhodus and Jonathan M. Schott and Ignacio Illán‐Gala and Chukwuanugo Ogbuagu and Jorge J. Llibre Guerra and Ruth Peters and Erin L. Abner and Carla Abdelnour and Albert Lladó and Renaud La Joie and Leonardo Cruz de Souza and Neguine Rezaii and Dror Shir and Yolande A. L. Pijenburg and Maria C. Carrillo and Bradford C Dickerson and Paul Aisen and Rik Ossenkoppele and Rema Raman},
year = {2026},
journal = {Alzheimer's \& Dementia},
doi = {10.1002/alz.71521},
url = {https://doi.org/10.1002/alz.71521}
}RIS
TY - JOUR TI - Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action AU - Nick Corriveau‐Lecavalier AU - Neus Falgàs AU - Deepti Putcha AU - Jonathan Graff‐Radford AU - Keir X. X. Yong AU - Baayla D. C. Boon AU - Rosaleena Mohanty AU - Eric Westman AU - Colin Groot AU - David T. Jones AU - Lea T. Grinberg AU - Gil D. Rabinovici AU - Jennifer L. Whitwell AU - Liana G. Apostolova AU - Melissa E. Murray AU - Dustin B. Hammers AU - Suzanne E. Schindler AU - Inga Atonsdottir AU - Elizabeth K. Rhodus AU - Jonathan M. Schott AU - Ignacio Illán‐Gala AU - Chukwuanugo Ogbuagu AU - Jorge J. Llibre Guerra AU - Ruth Peters AU - Erin L. Abner AU - Carla Abdelnour AU - Albert Lladó AU - Renaud La Joie AU - Leonardo Cruz de Souza AU - Neguine Rezaii AU - Dror Shir AU - Yolande A. L. Pijenburg AU - Maria C. Carrillo AU - Bradford C Dickerson AU - Paul Aisen AU - Rik Ossenkoppele AU - Rema Raman PY - 2026 JO - Alzheimer's & Dementia DO - 10.1002/alz.71521 UR - https://doi.org/10.1002/alz.71521 ER -
APA
Corriveau‐Lecavalier, N., Falgàs, N., Putcha, D., Graff‐Radford, J., Yong, K. X. X., Boon, B. D. C., Mohanty, R., Westman, E., Groot, C., Jones, D. T., Grinberg, L. T., Rabinovici, G. D., Whitwell, J. L., Apostolova, L. G., Murray, M. E., Hammers, D. B., Schindler, S. E., Atonsdottir, I., Rhodus, E. K., Schott, J. M., Illán‐Gala, I., Ogbuagu, C., Guerra, J. J. L., Peters, R., Abner, E. L., Abdelnour, C., Lladó, A., Joie, R. L., Souza, L. C. D., Rezaii, N., Shir, D., Pijenburg, Y. A. L., Carrillo, M. C., Dickerson, B. C., Aisen, P., Ossenkoppele, R., & Raman, R. (2026). Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71521
Source records
- crossref · retrieved 2026-09-26T10:29:07.323Z